Target intelligence / Profile preview

Novel transcript, antisense to UNC5A (null)

Target
null
Molecular classification
Other, natural antisense transcript, non-coding RNA
01

Overview

This entity represents a **natural antisense transcript (NAT)** transcribed from the DNA strand opposite to the UNC5A (Unc-5 netrin receptor A) gene. NATs are a well-documented component of eukaryotic transcriptomes and exert various regulatory influences on their sense counterparts. Ribosome association and protein-coding potential are generally lacking for such NATs; instead, they commonly affect sense gene expression post-transcriptionally or transcriptionally[3][4]. Specifically, NATs can modulate chromatin architecture, alter transcript stability, suppress or enhance translation, or modify pre-mRNA splicing patterns of target genes[3][1][4]. In the case of this transcript, its function would be presumed to regulate UNC5A expression—possibly influencing neuronal development or cellular apoptosis, given the known roles of UNC5A[2]—but there is currently no experimental evidence that validates a direct biological effect or a disease association for this specific antisense transcript. There are no approved drugs or clinical development programs targeting it, and it is not established as a therapeutic target. Note: - *ENSG00000294630 does not represent a protein-coding gene or classical "therapeutic target" but is rather an annotated non-coding antisense RNA.* - *UNC5A, the gene to which it is antisense, encodes a netrin receptor involved in axon guidance and apoptosis, but this antisense transcript is not equivalent to UNC5A itself[2].* - *Such transcripts are abundant in the genome and mostly remain functionally uncharacterized, though their regulatory functions are increasingly recognized.*

Other names
Antisense transcript to UNC5Aantisense to Unc-5 netrin receptor Amay appear in databases as "ENSG00000294630"
02

Mechanism of action

null

03

Biological functions

Regulation of gene expression (cis-regulation of sense transcript)[3][4]Chromatin modification/modulation of transcriptional dynamics[1]Possible participation in RNA interference or masking microRNA target sites[3]
04

Disease associations

Othertentative, as dysregulation of NATs can affect associated gene pathways, but no direct evidence for a specific disease for this NAT

Beyond the preview

Go deeper on Novel transcript, antisense to UNC5A (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to UNC5A (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call